A.1.1KIRATLI PO,VOLKAN-SALANCI B, GÜNAY EC, VARAN A, AKYÜZ C, BÜYÜKPAMUKÇU M. THYROID CANCER IN PEDIATRIC AGE GROUP: AN INSTITUTIONAL EXPERIENCE AND REVIEW OF THE LITERATURE. J PEDIATR HEMATOL ONCOL. 2013 MAR;35(2):93-7. A.1.2VOLKAN-SALANCI B,AKSOY H, KIRATLI PÖ, TÜLÜMEN E, GÜLER N, ÖKSÜZOGLU B,TOKGÖZOĞLU L, ERBAŞ B, ALIKAŞIFOĞLU M. THE RELATIONSHIP BETWEEN CHANGES IN FUNCTIONAL CARDIAC PARAMETERS FOLLOWING ANTHRACYCLINE THERAPY AND CARBONYL REDUCTASE 3 AND GLUTATHIONE S TRANSFERASE PI POLYMORPHISMS. J CHEMOTHER. 2012 OCT;24(5):285-91. A.1.3ERGÜN E.L.,VOLKAN-SALANCI B.,ERTUĞRUL A., DEMIR B., ERBAŞ B. EVALUATION OF SISCOM IN ROUTINE REGIONAL BLOOD FLOW ALTERATIONS AFTER CLOZAPINE IN SCHIZOPHRENIA.HELL J NUCL MED2010; 13(1): 35-39. A.1.4KIRATLI P.O., DEMIR A.U.,VOLKAN-SALANCI B.,DEMIR B., SAHIN A. CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTION IN OBSTRUCTIVE SLEEP APNEA SYNDROME.HELL J NUCL MED.2010 MAY-AUG;13(2):138-43. A.1.5ERTUGRUL A,VOLKAN-SALANCI B.,BASAR K, KARLI OGUZ K, DEMIR B, ERGUN EL, SENTURK S, ERBAS B. A CILA, B ULUG. THE EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW AND BRAIN METABOLITE RATIOS IN SCHIZOPHRENIA: RELATIONSHIP WITH TREATMENT RESPONSE.PSYCHIATRY RES. 2009 NOV 30;174(2):121-9. A.1.6VOLKAN-SALANCI B.,DAGDELEN S., ALIKASIFOGLU M., ERBAS T., HAYRAN M., ERBAS B. IMPACT OF RENIN-ANGIOTENSIN SYSTEM POLYMORPHISMS ON RENAL HAEMODYNAMIC RESPONSIVENESS TO ACUTE ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN TYPE 2 DIABETES MELLITUS.JRAAS2009 MAR 10(1): 41-50 (NÜKLEER TIP UZMANLIK TEZINDEN ÜRETILMIŞ YAYINDIR). A.1.7VOLKAN -SALANCI B., KIRATLI P.O., DEMIR A., SELCUK T.RISK FACTORS OF PULMONARY THROMBOEMBOLISM IN PATIENTS FROM A UNIVERSITY HOSPITAL.SAUDI MED J.2007 APR;28(4):574-8. A.1.8ERDOGAN S., OZER A.Y.,VOLKAN B., CANER B., BILGILI H. THROMBUS LOCALIZATION BY USING STREPTOKINASE CONTAINING VESICULAR SYSTEMS. DRUG DELIV. 2006 JUL-AUG;13(4):303-9. A.1.9UGURO., KARA P.O., BOZKURT M.F.,HAMALOGLUE.,TEZELG.G.,SALANCIB.V.,KARABULUTE.,SAYEKI. IN VIVO CHARACTERISATION OF PARATHYROID LESIONS BY USE OF GAMMA PROBE: COMPARISON WITH EX VIVO COUNT METHOD AND FROZEN SECTION RESULTS.OTOLARYNGOL HEAD NECK SURG.2006 FEB;134(2):316-320. A.1.10MUMCUOGLU E.U., NAR F., YARDIMCI Y., KOCAK U., ERGUN E.L.,SALANCI B.V.,UGUR O, ERBAS B. SIMULTANEOUS SURFACE REGISTRATION OF ICTAL AND INTERICTAL SPECT AND MAGNETIC RESONANCE IMAGES FOR EPILEPSY STUDIES.NUCL MED COMMUN.2006 JAN;27(1):45-55. A.1.11GÜNAY E.C., ÖZTÜRK M.H., ERGÜN E.L., ALTUN B.,VOLKAN-SALANCI B.,UĞUR Ö., ÇIL B., HEKIMOĞLU B., CANER B. LOSARTAN RENOGRAPHY IN COMPARISON WITH CAPTOPRIL FOR DETECTION OF RENAL ARTERY STENOSIS: WHICH DOSE AND WHAT TIME?EUR J NUCL MED MOL IMAG.2005; 32:1064-1074. A.1.12UTINE GE, HALILOĞLU G,VOLKAN-SALANCI B, CETINKAYA A, KIPER PO, ALANAY Y, AKTAŞ D, ANLAR B, TOPÇU M, BODUROĞLU K, ALIKAŞIFOĞLU M. ETIOLOGICAL YIELD OF SNP MICROARRAYS IN IDIOPATHIC INTELLECTUAL DISABILITY. EUR J PAEDIATR NEUROL. 2014 JAN 25. PII: S1090-3798(14)00010-5. DOI:10.1016/J.EJPN.2014.01.004. A.1.13UTINE GE, AKPINAR B, ARSLAN U, KIPER PÖ,VOLKAN-SALANCI B, ALANAY Y, AKTAŞ D, HALILOĞLU G, OĞUZ KK, BODUROĞLU K, ALIKAŞIFOĞLU M. NEUROCHEMICAL EVALUATION OF BRAIN FUNCTION WITH 1H MAGNETIC RESONANCE SPECTROSCOPY IN PATIENTS WITH FRAGILE X SYNDROME. AM J MED GENET A. 2014 JAN;164A(1):99-105. DOI: 10.1002/AJMG.A.36207. A.1.14BAYRAK A, BAYRAK T, TOKGÖZOGLU SL,VOLKAN-SALANCI B, DENIZ A, YAVUZ B, ALIKASIFOGLU M, DEMIRPENÇE E. SERUM PON-1 ACTIVITY BUT NOT Q192R POLYMORPHISM IS RELATED TO THE EXTENT OF ATHEROSCLEROSIS. J ATHEROSCLER THROMB. 2012;19(4):376-84. A.1.15UTINE GE, KIPER PO,SALANCI BV,ALANAY Y, AKTAŞ D, ALIKAŞIFOĞLU M, BODUROĞLU K, TUNÇBILEK E. OPINIONS OF TURKISH PHYSICIANS TOWARDS TERMINATION OF PREGNANCY FOR FETAL DISORDERS. GENET COUNS. 2011;22(4):401-9. A.1.16BERKER N., ALANAY Y.,ELGIN U.,VOLKAN-SALANCI B.,SIMSEK T., AKARSU N., ALIKASIFOGLU M. A NEW AUTOSOMAL DOMINANT PETERS’ ANOMALY PHENOTYPE EXPANDING THE ANTERIOR SEGMENT DYSGENESIS SPECTRUM.ACTA OPHTHALMOL2009 FEB;87(1):52-7. A.1.17ALANAY Y., UNAL F., TURANLI G., ALIKASIFOGLU M., ALEHAN D., AKYOL U., BELGIN E., SENER C., AKTAS D., BODUROGLU K., UTINE E.,VOLKAN-SALANCI B., OZUSTA S., GENC A., BASAR F., SEVINC S., TUNCBILEK E.A MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF INDIVIDUALS WITH FRAGILE X SYNDROME.J INTELLECT DISABIL RES. 2007 FEB;51(PT 2):151-61. A.1.18CEYLAN E.,VOLKAN B., BARISTA I., CANER B. LUNG HILAR GA-67 UPTAKE IN PATIENTS WITH LYMPHOMA FOLLOWING CHEMOTHERAPY.ANNALS NUCL MED2004 18(5):391-397. A.1.19CAGLAR M.,VOLKAN B.,ALPAR R. RELIABILITY OF RADIONUCLIDE GASTROESOPHAGEAL REFLUX STUDIES USING VISUAL AND TIME-ACTIVITY CURVE ANALYSIS: INTER-OBSERVER AND INTRA-OBSERVER VARIATION AND DESCRIPTION OF MINIMUM DETECTABLE REFLUX.NUCL MED COMMUN2003 24:421-428. A.1.20KIRATLI P.O.,SALANCI B.V.TESTING DIFFERENT STORAGE CONDITIONS FOR99MTC- MAG3KIT: CAN HOT FRACTIONING REDUCE THE COST PER UNIT DOSE?J NUCL MED TECHNOL2003 31(2):74-75.

Molecular imaging, Neurology, Oncology, radionuclide therapy

High School	Ankara Gazi Anadolu Lisesi 1992
Univercity	Hacettepe Üniversitesi Tıp Fakültesi 1998
Academic Background	Postgraduate / Hacettepe Üniversitesi Genetik 2010 Specialty / Hacettepe Üniversitesi Nükleer tıp 2004
Foreign Experience / Education	Max-Planck Institute for Neurological Resaearch, Laboratory for Gene Therapy and Molecular Imaging. Cologne, Germany Reseach Fellow. 01/01/2008 -30/04/2008.

: (312) 305 13 36

: bilgev@hacettepe.edu.tr